Impact of a transcutaneous bilirubinometry program on resource utilization and severe hyperbilirubinemia
- PMID: 22184646
- DOI: 10.1542/peds.2011-0599
Impact of a transcutaneous bilirubinometry program on resource utilization and severe hyperbilirubinemia
Abstract
Objectives: Our goal was to assess the impact of programmatic and coordinated use of transcutaneous bilirubinometry (TcB) on the incidence of severe neonatal hyperbilirubinemia and measures of laboratory, hospital, and nursing resource utilization.
Methods: We compared the neonatal hyperbilirubinemia-related outcomes of 14 796 prospectively enrolled healthy infants ≥35 weeks gestation offered routine TcB measurements in both hospital and community settings by using locally validated nomograms relative to a historical cohort of 14 112 infants assessed by visual inspection alone.
Results: There was a 54.9% reduction (odds ratio [OR]: 2.219 [95% confidence interval (CI): 1.543-3.193]; P < .0001) in the incidence of severe total serum bilirubin values (≥342 µmol/L; ≥20 mg/dL) after implementation of routine TcB measurements. TcB implementation was associated with reductions in the overall incidence of total serum bilirubin draws (134.4 vs 103.6 draws per 1000 live births, OR: 1.332 [95% CI: 1.226-1.446]; P < .0001) and overall phototherapy rate (5.27% vs 4.30%, OR: 1.241 [95% CI: 1.122-1.374]; P < .0001), a reduced age at readmission for phototherapy (104.3 ± 52.1 vs 88.9 ± 70.5 hours, P < .005), and duration of phototherapy readmission (24.8 ± 13.6 vs 23.2 ± 9.8 hours, P < .05). There were earlier (P < .01) and more frequent contacts with public health nurses (1.33 vs 1.66, P < .01) after introduction of the TcB program.
Conclusions: Integration of routine hospital and community TcB screening within a comprehensive public health nurse newborn follow-up program is associated with significant improvements in resource utilization and patient safety.
Similar articles
-
Transcutaneous bilirubinometry for detecting jaundice in term or late preterm neonates.Cochrane Database Syst Rev. 2024 May 28;5(5):CD011060. doi: 10.1002/14651858.CD011060.pub2. Cochrane Database Syst Rev. 2024. PMID: 38804265 Review.
-
Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia.J Perinatol. 2009 Sep;29(9):612-7. doi: 10.1038/jp.2009.43. Epub 2009 May 7. J Perinatol. 2009. PMID: 19421200
-
Effect of universal neonatal transcutaneous bilirubin screening on blood draws for bilirubin analysis and phototherapy usage.J Perinatol. 2012 Nov;32(11):851-5. doi: 10.1038/jp.2012.10. Epub 2012 Feb 16. J Perinatol. 2012. PMID: 22343396
-
Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.J Pediatr. 2013 Mar;162(3):477-482.e1. doi: 10.1016/j.jpeds.2012.08.022. Epub 2012 Oct 5. J Pediatr. 2013. PMID: 23043681
-
Point of care testing: transcutaneous bilirubinometry in neonates.Clin Biochem. 2009 Feb;42(3):143-9. doi: 10.1016/j.clinbiochem.2008.09.106. Epub 2008 Oct 2. Clin Biochem. 2009. PMID: 18929553 Review.
Cited by
-
Transcutaneous bilirubinometry for detecting jaundice in term or late preterm neonates.Cochrane Database Syst Rev. 2024 May 28;5(5):CD011060. doi: 10.1002/14651858.CD011060.pub2. Cochrane Database Syst Rev. 2024. PMID: 38804265 Review.
-
Transcutaneous bilirubin reliability during and after phototherapy depending on skin color.Eur J Pediatr. 2024 Jul;183(7):2819-2830. doi: 10.1007/s00431-024-05516-4. Epub 2024 Apr 6. Eur J Pediatr. 2024. PMID: 38581462 Free PMC article.
-
Transcutaneous bilirubinometry versus total serum bilirubin measurement for newborns.Cochrane Database Syst Rev. 2023 May 9;5(5):CD012660. doi: 10.1002/14651858.CD012660.pub2. Cochrane Database Syst Rev. 2023. PMID: 37158489 Free PMC article. Review.
-
Universal screening for hyperbilirubinemia in term healthy newborns at discharge: A systematic review and meta-analysis.J Glob Health. 2022 Dec 29;12:12007. doi: 10.7189/jogh.12.12007. J Glob Health. 2022. PMID: 36579719 Free PMC article.
-
Effects of a Smartphone-Based Out-of-Hospital Screening App for Neonatal Hyperbilirubinemia on Neonatal Readmission Rates and Maternal Anxiety: Randomized Controlled Trial.J Med Internet Res. 2022 Nov 23;24(11):e37843. doi: 10.2196/37843. J Med Internet Res. 2022. PMID: 36416882 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
